Forest Laboratories and Almirall announced that Tudorza Pressair (aclidinium bromide inhalation powder) is now available in U.S. pharmacies.

Tudorza Pressair is a long-acting anticholinergic indicated for long-term, maintenance treatment of bronchospasm associated with COPD, ­including chronic bronchitis and emphysema. Tudorza produces bronchodilation by inhibiting the muscarinic M3 receptor in the airway smooth muscle. The bronchodilation following inhalation of aclidinium bromide is predominantly a site-specific effect.

Tudorza is a preloaded Pressair inhaler available in 30- or 60-metered doses containing 400mcg per actuation.

For more information call (800) 678-1605 or visit www.tudorza.com.